|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$113,939
|
N/A
|
National Cancer Institute
|
|
Defining mechanisms and targets in Wnt addicted human malignancies (PQ22)
|
5R01CA170702-02
|
$330,610
|
$330,610
|
AARONSON, STUART
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
BIOMOLECULAR ANALYSIS USING LIQUID CRYSTALS
|
5R01CA108467-09
|
$351,853
|
$87,963
|
ABBOTT, NICHOLAS
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Molecular interactions and restoration strategies of PTEN and p53 in gliomas
|
5R01CA134843-04
|
$291,367
|
$291,367
|
ABOUNADER, ROGER
|
UNIVERSITY OF VIRGINIA
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$700,734
|
$350,367
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-11
|
$24,894,951
|
$1,991,596
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Genetically-Modified Neural Stem Cell Based Virotherapy for Invasive Gliomas
|
4R00CA160775-02
|
$233,998
|
$233,998
|
Ahmed, Atique
|
UNIVERSITY OF CHICAGO
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$36,212
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
$2,250
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance
|
5R01CA153050-04
|
$297,042
|
$297,042
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,156,216
|
$11,562
|
Alter, Blanche
|
DCEG (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
$70,825
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Annexin A2 as a Novel Enhancer of Tumor-Associated Antigen Processing
|
1F30CA167912-01A1
|
$42,232
|
$42,232
|
Andersen, Brian
|
UNIVERSITY OF MINNESOTA
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-04
|
$317,669
|
$63,534
|
Anderson, Bradley
|
UNIVERSITY OF KENTUCKY
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-11
|
$5,797,460
|
$463,797
|
ANDERSON, JAMES
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Quantify treatment response in IDH1 mutant glioma patients with metabolic MRI
|
1K22CA178269-01
|
$200,552
|
$200,552
|
Andronesi, Ovidiu
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Understanding Mechanisms of Resistance to Anti-angiogenic Treatments
|
5R01CA160216-02
|
$434,211
|
$434,211
|
ARBAB, ALI
|
HENRY FORD HEALTH SYSTEM
|
|
In vivo detection of involvement of endogenous BM progenitor cells in glioma
|
5R01CA172048-02
|
$285,749
|
$285,749
|
ARBAB, ALI
|
HENRY FORD HEALTH SYSTEM
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-27
|
$1,874,946
|
$18,749
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
|
5R01CA155769-03
|
$327,684
|
$327,684
|
BADIE, BEHNAM
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Meso-plex miRNA and protein profiling for cancer diagnostics using chip-integrate
|
1R33CA177462-01
|
$347,739
|
$347,739
|
Bailey, Ryan
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
|
Normal & Neoplastic Growth in the Brain
|
5P01CA096832-10
|
$1,798,280
|
$1,798,280
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer-Associated, Interdependent Regulation of mTOR, AKT, and IKK/NF-kappaB
|
5R01CA075080-15
|
$277,527
|
$138,764
|
BALDWIN, ALBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Platform for MR-Guided Neurotherapeutic Drug Delivery
|
1R43CA177205-01A1
|
$216,225
|
$216,225
|
Barker, Edward
|
INSERT, INC.
|
|
Interplay between intrinsic and extrinsic force and glioma aggression
|
1F32CA174319-01
|
$53,870
|
$53,870
|
Barnes, Matt
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
SPORE: Targeted Therapies for Glioma
|
1P50CA165962-01A1
|
$2,150,500
|
$2,150,500
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Angiogenesis-targeting therapy for glioblastoma
|
2R01CA129371-06
|
$594,234
|
$594,234
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Training Program in Nervous System Tumors
|
5K12CA090354-13
|
$658,580
|
$658,580
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Clinical and Molecular Studies of Malignant Brain Tumors
|
5K24CA125440-07
|
$185,972
|
$139,479
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$128,818
|
$25,764
|
Bates, Susan
|
CCR (NCI)
|
|
Enhancing dendritic cell migration to drive potent anti-tumor immune responses
|
1F30CA180411-01
|
$47,232
|
$47,232
|
Batich, Kristen
|
DUKE UNIVERSITY
|
|
18F-Fluorocholine to distinguish necrosis from recurrence in brain metastases
|
1R21CA170289-01A1
|
$366,860
|
$366,860
|
Beal, Kathryn
|
SLOAN-KETTERING INST CAN RES
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-29
|
$1,065,000
|
$10,650
|
Bearden, James
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA042014-24S1
|
$43,750
|
$438
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-24
|
$1,433,304
|
$14,333
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Iowa Oncology Research Association
|
5U10CA035101-28
|
$747,553
|
$14,951
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
'Exvading' Invasive Pediatric Brain Tumors
|
5R01CA153229-04
|
$231,106
|
$231,106
|
Bellamkonda, Ravi
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
|
5R01CA158534-02
|
$285,749
|
$285,749
|
Benveniste, Etty
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Cancer Center Support Grant
|
3P30CA006516-48S1
|
$114,538
|
$6,872
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S3
|
$12,500
|
$750
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S4
|
$50,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-48
|
$10,435,722
|
$626,143
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-20
|
$736,823
|
$14,736
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Systematic Development of Novel, Druggable Cancer Targets
|
5U01CA168397-02
|
$783,005
|
$783,005
|
BERENS, MICHAEL
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
|
SPORE: Brain Tumor SPORE Grant
|
2P50CA097257-11A1
|
$2,150,500
|
$2,150,500
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Biophysical and molecular dialogue of glioma cells and the brain microenvironment
|
5U54CA163155-03
|
$78,542
|
$78,542
|
BERGERS, GABRIELE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-15
|
$596,700
|
$179,010
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CAN RES CTR
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-35
|
$239,826
|
$23,983
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CAN RES CTR
|
|
Pediatric CT Scans
|
ZIA CP010222-04122
|
$616,881
|
$185,064
|
Berrington, Amy
|
DCEG (NCI)
|
|
Signal processing for accurate detection of copy number variants in cancer
|
5R03CA165070-02
|
$78,750
|
$39,375
|
Betensky, Rebecca
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
Total relevant funding to Brain for this search: $171,170,883
|